Literature DB >> 22464840

[Circumcision in children: an organizational or an ethical challenge?].

L Beydon1, C Ecoffey, A Lienhart, L Puybasset.   

Abstract

OBJECTIVES: To review society, ethical and anaesthesiological issues related to circumcision in children. STUDY
DESIGN: Review.
METHODS: Pubmed search and expert opinion
RESULTS: Circumcision concerns 30 of male world population. Reasons are ritual, medical and hygienic. In Muslims, circumcision is usual performed before the age of six. Surgery is performed at best under sevoflurane general anaesthesia and a penile bloc. Level 1 and level 2 antalgics are used for 72 hours, once the bloc has elapsed. In Jews, circumcision is performed soon after birth, in the community. Emla is the most convenient antalgics in this case. Except in case of emergency, circumcision under general anaesthesia should be delayed after 3 months as general anaesthesia is suspect to exert cerebral toxicity. Before the age of one year, there is a risk of increased respiratory problems following general anesthesia. Therefore, circumcision under general anaesthesia should be performed after one year of age. Circumcision may represent an adjunct to limit AIDS transmission in endemic countries.
CONCLUSION: The ethical point associated with circumcision is to allow best analgesia, in a way matching child's age. Analgesia, is achievable by both the surgeon and the anesthesiologist.
Copyright © 2012. Published by Elsevier SAS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464840     DOI: 10.1016/j.annfar.2012.01.038

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  2 in total

1.  Efficacy of Dexmedetomidine Anesthesia plus Dorsal Penile Nerve Block in Pediatric Circumcision.

Authors:  Ling Ji; Fan Yao; Yanwu Wang; Caishun Li; Yulong Lin
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-30       Impact factor: 2.650

2.  At what age range should children be circumcised?

Authors:  Senol Bicer; Ufuk Kuyrukluyildiz; Fethi Akyol; Murat Sahin; Orhan Binici; Didem Onk
Journal:  Iran Red Crescent Med J       Date:  2015-03-20       Impact factor: 0.611

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.